Skip to main content
. 2021 May 24;12:650313. doi: 10.3389/fphys.2021.650313

Table 1.

Summary of probiotics effects on epithelial barrier function in vitro and in vivo.

Probiotic Effect in epithelial barrier Model References
Bifidobacterium longum * Increase the production of acetate and prevent the reduction in TEER resulting from E. coli O157-induced cell death. Caco-2 Fukuda et al., 2011, 2012
Bacteroides thetaiotaomicron * Acetate-producing bacteria, favors goblet cell differentiation and mucus secretion. Rats Wrzosek et al., 2013
Faecalibacterium prausnitzii * Acetate consumer and butyrate-producing bacteria, modulates the intestinal mucus barrier when supplemented in combination with B. thetaiotaomicron. Rats Wrzosek et al., 2013
Lactobacillus casei ** Reverses the cytokine-induced dysfunction of TEER, epithelial permeability, and ZO-1 expression. Caco-2 Eun et al., 2011
B. animalis ssp. lactis CNCM-I2494** Protects barrier integrity by restoring intestinal permeability, colonic goblet cell populations, and cytokine levels. Furthermore, normalizes the level of several TJ proteins, in particular claudin-4. Mice Martín et al., 2016
Lactobacillus plantarum ZLP001* Modulates butyrate-producing enteric microbiota to induce the expression of epithelial host-defense peptides and to enhance intestinal Lactobacillus abundance to improve the gut microbiota composition and reinforce TJs. Weaned piglets Wang et al., 2018
L. acidophilus *
Streptococcus thermophilus *
Increases TEER, decreases permeability, and induces the activation of occludin and ZO-1, shown by increased levels of phosphorylated proteins. Caco-2
HT-29
Resta-Lenert and Barrett, 2003
*

Probiotics that are part of the human intestinal microbiota.

**

Probiotics that, normally, are not present in the human intestinal microbiota.